Clearing the Smoke:
Cannabis and Mental Health

A Two-Part Webinar Series  |  April 8 and 15

Join the American Psychiatric Association (APA) and the American Academy of Addiction Psychiatry (AAAP) for a two-part webinar series to learn about cannabis. The first webinar will provide an overview and updates on cannabis use in patients, mental health impacts and clinical practice recommendations based on the latest research, and the second will provide a follow-up session to provide more insights and answer attendee questions on cannabis, psychiatry/addiction psychiatry, and patients. Presenters include:

  • Arthur Robin Williams, M.D., M.B.E., Assistant Professor of Clinical Psychiatry, Columbia University Division on Substance Use Disorders; Research Scientist, New York State Psychiatric Institute
  • Kevin Hill, M.D., M.H.S., Director of the Division of Addiction Psychiatry at Beth Israel Deaconess Medical Center and an Associate Professor of Psychiatry at Harvard Medical School
  • Smita Das, M.D., Ph.D., M.P.H., Medical Director of Psychiatry at Lyra Health and Clinical Assistant Professor at Stanford School of Medicine.

Part One

  • Thursday, April 8
  • 1:00 – 2:00 p.m. EST
  •  AMA PRA Category 1 Credit™
  • Recordings coming soon, please check back for more information.
Learning Objectives
  • Explain the fundamental elements of cannabis components and epidemiology.
  • Assess for use of cannabis and impacts of use as they related to mental health visits.
  • Implement a clinical practice rooted in research to address cannabis.

Part Two

  • Thursday, April 15
  • 1:00 – 2:00 p.m. EST
  •  AMA PRA Category 1 Credit™
  • Recordings coming soon, please check back for more information.
Learning Objectives
  • Discuss evidence-based screening for cannabis use.
  • Review consensus behavioral interventions for cannabis use disorder.
  • Evaluate the evidence for various pharmacotherapies for cannabis use disorder.
  • Identify at least one resource to utilize in the ongoing education of patients.

The Current State of Cannabis

4.8 million Americans ages 12 and older were diagnosed with cannabis use disorder in 2019. As of 2020, there are 34 states and Washington, D.C., in which medical marijuana is legal, and 15 states and Washington, D.C., where cannabis is recreationally legal. Yet, on a national level, cannabis remains a Schedule I Substance under the Controlled Substances Act, limiting research on the drug. With cannabis becoming more readily available, psychiatrists and mental health professionals need to have the most updated information available on cannabis and to help patients make informed decisions.

Accreditation

The American Psychiatric Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Clearing the Smoke: Cannabis and Mental Health Part 1: The APA designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.
  • Clearing the Smoke: Cannabis and Mental Health Part 2: The APA designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.

Disclosures

  • Kathryn Cates-Wessel Reports no financial relationships with commercial interests.
  • Smita Das, MD Dr. Jones discloses the following relationships: Stock: Equity in Lyra Health.
  • Kevin Hill, MD Dr. Hill discloses the following relationships: Grant/Research: Greenwich Biosciences Other: Wolters-Kluwer (Author).
  • Alexis Victor Reports no financial relationships with commercial interests.
  • Jose Vito, MD Reports no financial relationships with commercial interests.
  • Arthur Williams, MD Reports no financial relationships with commercial interests.
  • Jill Williams, MD Reports no financial relationships with commercial interests.

Relevant Resources

Cannabis Toolkit

AAAP Position and Advocacy Statements

In Partnership

describes image